Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A. +6 more·1998·Journal of Neural Transmission
DOI 10.1007/s007020050068

Cited by (746)

Items 501–600 of 746

  1. Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer’s Disease
    Ignazio Stefano Piras, Danielle L. Brokaw, Yinfei Kong, Daniel J. Weisenberger, Jonida Krate, Elaine Delvaux, Swapna Mahurkar‐Joshi, Adam Blattler, Kimberly D. Siegmund, Lucia I. Sue et al. · 2023 · Cellular and Molecular Neurobiology
  2. Diabetes and the Nervous System
    Douglas William Zochodne, Cory C. Toth · 2014 · Elsevier eBooks
  3. Enhancing Brain Functions in Senior Dogs: A New Nutritional Approach
    Yuanlong Pan · 2011 · Topics in companion animal medicine
  4. Expression of Cholinergic, Insulin, Vitamin D Receptors and GLUT 3 in the Brainstem of Streptozotocin Induced Diabetic Rats: Effect of Treatment with Vitamin D3
    T. Peeyush Kumar, Jes Paul, Sherin Antony, C.S. Paulose · 2011 · Neurochemical Research
  5. Commonality Between Diabetes and Alzheimer’s Disease and A New Strategy for the Therapy
    Lin Li · 2008 · Clinical medicine Pathology
  6. The insulin gene VNTR polymorphism in Alzheimer's disease: results of a pilot study
    Michael Majores, Heike Kölsch, M. Bagli, Ursula Ptok, Martin Kockler, Kathrin Becker, M. L. Rao, Wolfgang Maier, Reinhard Heun · 2002 · Journal of Neural Transmission
  7. Altered subcellular localization of ornithine decarboxylase in Alzheimer’s disease brain
    Tatjana Nilsson, Nenad Bogdanović, Inga Volkmann, Bengt G. Winblad, Ronnie Folkesson, Eiríkur Benedikz · 2006 · Biochemical and Biophysical Research Communications
  8. Insulin potentiates the therapeutic effect of memantine against central STZ-induced spatial learning and memory deficit
    Abbas Bahramian, Karim Rastegar, Mohammad Reza Namavar, Maryam Moosavi · 2016 · Behavioural Brain Research
  9. A unifying hypothesis of Alzheimer's disease. I. Ageing sets the stage
    Kurt Heininger · 1999 · Human Psychopharmacology Clinical and Experimental
  10. Up-Regulation of Cell Surface Insulin Receptor by Protein Kinase C-α in Adrenal Chromaffin Cells
    Ryuichi Yamamoto, Hideyuki Kobayashi, Toshihiko Yanagita, Hiroki Yokoo, Takeshi Kurose, Seiji Shiraishi, Shin-ichi Minami, Shigeru Matsukura, Akihiko Wada · 2000 · Journal of Neurochemistry
  11. Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease
    Chun Zou, Xiaohua Huang, Yilong Zhang, Mika Pan, Jieqiong Xie, Liechun Chen, Youshi Meng, Donghua Zou, Jiefeng Luo · 2022 · Frontiers in Molecular Neuroscience
  12. Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up
    Ana Knezović, Melita Šalković‐Petrišić · 2025 · Journal of Neural Transmission
  13. Anti‐diabetic and neuroprotective effects of pancreatic islet transplantation into the central nervous system
    Daniel Lazard, Pnina Vardi, Konstantin O. Bloch · 2015 · Diabetes/Metabolism Research and Reviews
  14. A Genetic Model of Epilepsy with a Partial Alzheimer’s Disease-Like Phenotype and Central Insulin Resistance
    Suélen Santos Alves, Rui Milton Patrício da Silva-Júnior, Polianna Delfino-Pereira, Marília Gabriella Alves Goulart Pereira, Israel C. Vasconcelos, Hanna Schwaemmle, Rodrigo Focosi Mazzei, Maiko Luiz Carlos, Enilza Maria Espreáfico, Antônio Cláudio Tedesco et al. · 2022 · Molecular Neurobiology
  15. Streptozotocin causes acute responses on hippocampal S100B and BDNF proteins linked to glucose metabolism alterations
    Letícia Rodrigues, Krista Minéia Wartchow, Lucas Zingano Suardi, Bárbara Carolina Federhen, Nicholas Guerini Selistre, Carlos‐Alberto Gonçalves · 2019 · Neurochemistry International
  16. Amyloid Beta-Derived Diffusible Ligands (ADDLs) Induce Abnormal Expression of Insulin Receptors in Rat Hippocampal Neurons
    Xin Liu, Zongyan Teng, Can Cui, Ruitao Wang, Meiling Liu, Yina Zhang · 2014 · Journal of Molecular Neuroscience
  17. Down-regulation of cell surface insulin receptors by sarco(endo)plasmic reticulum Ca2+-ATPase inhibitor in adrenal chromaffin cells
    Seiji Shiraishi, Ryuichi Yamamoto, Toshihiko Yanagita, Hiroki Yokoo, Hideyuki Kobayashi, Yasuhito Uezono, Akihiko Wada · 2001 · Brain Research
  18. Reduced endothelial caveolin-1 underlies deficits in brain insulin signalling in type 2 diabetes
    Aashutosh Shetti, Abhirami Ramakrishnan, Liudmila G. Romanova, Wenping Li, Khanh Vo, Ipsita Volety, Ishara S. Ratnayake, Terilyn K. L. Stephen, Richard D. Minshall, Stephanie M. Cologna et al. · 2023 · Brain
  19. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
    Samo Ribarič · 2024 · International Journal of Molecular Sciences
  20. Region-specific association between basal blood insulin and cerebral glucose metabolism in older adults
    Min Soo Byun, Hyun Jung Kim, Dahyun Yi, Hyo Jung Choi, Hyewon Baek, Jun Ho Lee, Young Min Choe, Seung Hoon Lee, Kang Ko, Bo Kyung Sohn et al. · 2019 · NeuroImage Clinical
  21. Distribution of insulin in primate brain following nose‐to‐brain transport
    Kylie R. Smith, Jinda Fan, Gwendolyn A. Marriner, John M. Gerdes, ROBERT M. KESSLER, Kurt R. Zinn · 2024 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  22. Neuronal Insulin Receptor Signaling: A Potential Target for the Treatment of Cognitive and Mood Disorders
    Toshihiko Yanagita, Takayuki Nemoto, Shinya Satoh, Norie Yoshikawa, Toyoaki Maruta, Seiji Shiraishi, Chihiro Sugita, Manabu Murakami · 2013 · InTech eBooks
  23. Developing Trojan horses to induce, diagnose and suppress Alzheimer’s pathology
    Amal A. Aziz, Zareen Amtul · 2019 · Pharmacological Research
  24. Role of insulin in Alzheimer's disease:approaches emerging from basic animal research and neurocognitive studies in humans
    Werner Kern, Jan Born A, Horst Lorenz Fehm · 2002 · Drug Development Research
  25. Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance
    Rabab Al‐Lahham, Nicolás Méndez · 2023 · Journal of Alzheimer s Disease
  26. Review of Current Strategies for Delivering Alzheimer's Disease Drugs Across the Blood-Brain Barrier
    Ka Hong Wong, Muhammad Kashif Riaz, Yuning Xie, Xue Zhang, Qiang Liu, Huoji Chen, Zhaoxiang Bian, Xiaoyu Chen, Aiping Lü, Zhijun Yang · 2022 · FOCUS The Journal of Lifelong Learning in Psychiatry
  27. The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
    Guanying You, Jinyi Yao, Qiong Liu, Nan Li · 2022 · Current Issues in Molecular Biology
  28. Effect of acute lipopolysaccharide-induced inflammation in intracerebroventricular-streptozotocin injected rats
    Andrew S. Murtishaw, Chelcie F. Heaney, Monica M. Bolton, Jonathan J. Sabbagh, Michael A. Langhardt, Jefferson W. Kinney · 2015 · Neuropharmacology
  29. Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults
    Victoria J. Williams, Bianca A. Trombetta, Rabab Zehra Jafri, Aaron M. Koenig, Chase D. Wennick, Becky Catherine Carlyle, Laya Ekhlaspour, Rexford S. Ahima, Steven J. Russell, David H. Salat et al. · 2019 · JCI Insight
  30. The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
    Demi C. Galindo, William A. Banks, Elizabeth M. Rhea · 2020 · Endocrinology Diabetes & Metabolism
  31. Short-term fasting differentially regulates PI3K/AkT/mTOR and ERK signalling in the rat hypothalamus
    Tamara B. Dakic, Tanja V. Jevdjovic, Jelena D. Djordjevic, Predrag Z. Vujovic · 2020 · Mechanisms of Ageing and Development
  32. Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin
    Andrew L. Zhou, Nidhi Sharda, Vidur Sarma, Kristen M. Ahlschwede, Geoffry L. Curran, Xiaojia Tang, Joseph F. Poduslo, Krishna R. Kalari, Val J. Lowe, Karunya K. Kandimalla · 2021 · Journal of Alzheimer s Disease
  33. Gerontopsychiatrie in Deutschland. Gegenwärtige Entwicklung und zukünftige Anforderungen
    Hanfried Helmchen, Siegfried Kanowski · 2001 · VS Verlag für Sozialwissenschaften eBooks
  34. Steroid-induced elevation of glucose in Alzheimer’s disease: relationship to gender, apolipoprotein E genotype and cognition
    Paul S. S. Aisen, J.D. Berg, Suzanne Craft, Elaine R. Peskind, Mary Sano, Linda L Teri, Ruth A. Mulnard, Ronald G. Thomas, Leon J. Thal · 2003 · Psychoneuroendocrinology
  35. Insulin, Brain, Alzheimer’s Disease: New Evidence
    Svetlana Viktorovna Bulgakova, Романчук Петр Иванович, E. V. Treneva · 2020 · Bulletin of Science and Practice
  36. Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice
    Ruta Dekeryte, Claire E. Hull, Kaja Plucińska, Shakil A. Khan, Sarah Kamli-Salino, Nimesh Mody, Nicola Morrice, Chris M. McLaughlin, Victor A. Gault, Bettina Platt et al. · 2019 · Biochemical Pharmacology
  37. Moderate protective effect of Kyotorphin against the late consequences of intracerebroventricular streptozotocin model of Alzheimer’s disease
    Hristina Angelova, Daniela Pechlivanova, Ekaterina Tz. Krumova, Jeny Miteva‐Staleva, Nedelina Kostadinova, Elena B. Dzhambazova, Boycho V. Landzhov · 2019 · Amino Acids
  38. A Link Between Brain Insulin Resistance and Cognitive Dysfunctions: Targeting Ca2+/cAMP Signalling
    Leandro Bueno Bergantin · 2020 · Central Nervous System Agents in Medicinal Chemistry
  39. Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease
    Ahmet Turan Işık, Ergün Bozoğlu · 2009 · International Psychogeriatrics
  40. Relative expression of the p75 neurotrophin receptor, tyrosine receptor kinase A, and insulin receptor in SH-SY5Y neuroblastoma cells and hippocampi from Alzheimer's disease patients
    Shingo Ito, Michel Ménard, Trevor G. Atkinson, Leslie Brown, James Whitfield, Balu Chakravarthy · 2016 · Neurochemistry International
  41. N-Methyl-D aspartate receptor-mediated effect on glucose transporter-3 levels of high glucose exposed-SH-SY5Y dopaminergic neurons
    Ayşe Başak Engin, Doruk Engin, Resul Karakuş, Arzu Aral, Özlem Gülbahar, Atilla Engin · 2017 · Food and Chemical Toxicology
  42. Repurposing GLP1 agonists for neurodegenerative diseases
    Ioanna Markaki, Kristian Winther, Sergiu‐Bogdan Catrina, Per Svenningsson · 2020 · International review of neurobiology
  43. Falling Short: The Contribution of Central Insulin Receptors to Gait Dysregulation in Brain Aging
    Sami L. Case, Hilaree N. Frazier, Katie L. Anderson, Ruei‐Lung Lin, Olivier Thibault · 2022 · Biomedicines
  44. The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
    Jinyi Yao, Zhijun He, Guanying You, Qiong Liu, Nan Li · 2023 · Current Issues in Molecular Biology
  45. Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins.
    Bo Feng, Peng Hu, Shujun Lü, Rong Wang, Yifeng Du · 2014 · Europe PMC (PubMed Central)
  46. The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS – a critical overview
    Hans‐Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, Johann Steiner · 2022 · Reviews in the Neurosciences
  47. Evidence for pathophysiological commonalities between metabolic and neurodegenerative diseases
    Christian Hölscher · 2020 · International review of neurobiology
  48. Epigenetic Alterations in Alzheimer’s Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems
    Alosh Greeny, Ayushi Nair, Prashant Sadanandan, Sairaj Satarker, Ademola C. Famurewa, Madhavan Nampoothiri · 2024 · Biology
  49. A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer’s Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants
    Maria Tsamou, Francesca Pistollato, Erwin Roggen · 2021 · Journal of Alzheimer s Disease
  50. Effect of Caloric Restriction on Aging: Fixing the Problems of Nutrient Sensing in Postmitotic Cells?
    Моргунова Галина Васильевна, Gregory A. Shilovsky, Alexander N. Khokhlov · 2021 · Biochemistry (Moscow)
  51. Receptor tyrosine kinases
    Chinna Babu Pulivarthi, Shruti Shikha Choubey, Shivam Kumar Pandey, Avtar Singh Gautam, Rakesh Kumar Singh · 2023 · Elsevier eBooks
  52. Experimental Approach to Alzheimer’s Disease with Emphasis on Insulin Resistance in the Brain
    M. Šalković-Petrišić, Ana Babic Perhoc, J. Homolak, A. Knezović, J. Osmanovic-Barilar, P. Riederer · 2021 · Handbook of Neurotoxicity
  53. Proinsulin C peptide obviates sympathetically mediated suppression of splenic lymphocyte activity in rats
    Shiki Okamoto, Kazuhiro Kimura, Takanori Kitamura, Xavier Cañas, Takeshi Yoshida, Masayuki Saito · 2000 · Diabetologia
  54. Effect of IGF-I on DNA, RNA, and protein loss associated with brain atrophy and impaired learning in diabetic rats
    Sean B. Lupien, Erik J. Bluhm, Douglas N. Ishii · 2005 · Neurobiology of Disease
  55. Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease
    Suzanne M. de la Monte, Ming Tong · 2013 · Wiley eBooks
  56. Cerebrovascular insulin receptors are defective in Alzheimerˈs disease
    M. Leclerc, Philippe Bourassa, Cyntia Tremblay, Vicky Caron, Camille Sugère, Vincent Émond, David Alan Bennett, Frédéric Calon · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Editorial [Hot Topic: Progressive and Unconventional Pharmacotherapeutic Approaches to Alzheimers Disease Therapy (Guest Editors: Stuart Maudsley & Wayne Chadwick)]
    Stuart R. Maudsley, Wayne Chadwick · 2012 · Current Alzheimer Research
  58. Evidence for preserved insulin responsiveness in the aging rat brain
    Matthew G. Engel, Jeremy L. Smith, Kai Mao, Gabriela Farias Quipildor, Min‐Hui Cui, Maria E. Gulinello, Craig A. Branch, Sam Gandy, Derek M. Huffman · 2022 · GeroScience
  59. The Brain-insulin Connection, Metabolic Diseases and Related Pathologies
    Kyriaki Gerozissis · 2010 · Research and perspectives in Alzheimer's disease
  60. Endocrine dysfunction and cognitive impairment
    Valeria Calsolaro, Marina Bottari, Giulia Coppini, Bianca Lemmi, Fabio Monzani · 2021 · Minerva Endocrinology
  61. The Effect of Type-2 Diabetes on Cognitive Status and the Role of Anti-diabetes Medications
    Almothana Alkasabera, Chike B Onyali, Comfort Anim-Koranteng, Hira E Shah, Aarthi Ethirajulu, Nitin Bhawnani, Jihan A Mostafa · 2021 · Cureus
  62. Diabetes and the Nervous System
    Aaron I. Vinik, CAROLINA M. CASELLINI, Serina A. Neumann · 2020 · Endocrinology
  63. Dementia and diabetes mellitus
    Dragan M. Pavlović, Aleksandra M. Pavlovic · 2008 · Srpski arhiv za celokupno lekarstvo
  64. Lack of Association Between the Leptin Receptor Gene (LEPR) Gln223Arg Polymorphism and Late-onset Alzheimer Disease
    Kensuke Utsunomiya, Takahiro Shinkai, Shinichi Sakata, Rudi Hwang, Kenji Yamada, Hsin‐I Chen, Yuko Fukunaka, Osamu Ohmori, Jun Nakamura · 2010 · Alzheimer Disease & Associated Disorders
  65. Vascular Risk Factors for Alzheimer’s Disease
    Monique M.B. Breteler · 2000 · Springer eBooks
  66. Proteases and Alzheimer’s Disease: Present Knowledge and Emerging Concepts of Therapy
    Hans‐Gert Bernstein · 2006 · Springer eBooks
  67. Neuroendocrinology‐based therapy for Alzheimer's disease
    Russell F. Palm, Nilmarie Ayala‐Fontanez, Yoelvis García, Hyoung‐gon Lee, Mark A. Smith, Gemma Casadesús · 2012 · BioFactors
  68. A Perspective to the Correlation Between Brain Insulin Resistance and Alzheimer: Medicinal Chemistry Approach
    Navid Rabiee, Mojtaba Bagherzadeh, Mohammad Rabiee · 2018 · Current Diabetes Reviews
  69. Nutraceuticals in neurodegenerative diseases
    Sharmistha Banerjee, Sayanta Dutta, Sumit Ghosh, Parames Chandra Sil · 2020 · Elsevier eBooks
  70. Neuronal Elements in the Pathogenesis of Type 1 Diabetes
    Hubert Tsui, Shawn Winer, George Jakowsky, H.‐Michael Dosch · 2003 · Reviews in Endocrine and Metabolic Disorders
  71. Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents
    Hilaree N. Frazier, Katie L. Anderson, Shaniya Maimaiti, Adam O. Ghoweri, Susan D. Kraner, Gabriel J. Popa, Kaia K. Hampton, Michael D. Mendenhall, Christopher Mark Norris, Rolf J. Craven et al. · 2018 · Neurochemical Research
  72. Insulin receptor signaling regulates actin cytoskeletal organization in developing photoreceptors
    Raju V. S. Rajala, Ammaji Rajala, Richard S. Brush, Nora P. Rotstein, Luis E. Politi · 2009 · Journal of Neurochemistry
  73. Intranasal Insulin Mitigates Memory Impairment and Neuroinflammation in a Mouse Model of Hippocampal Aging
    Rajasekar Nagarajan, Han Zhang, Jinrui Lyu, Maltesh Kambali, Muxiao Wang, Uwe Rudolph · 2025 · Pharmacology Research & Perspectives
  74. Experimental Approach to Alzheimer’s Disease with Emphasis on Insulin Resistance in the Brain
    Melita Šalković‐Petrišić, Ana Babić Perhoč, Jan Homolak, Ana Knezović, Jelena Osmanović Barilar, Peter Franz Riederer · 2022 · Springer eBooks
  75. IGF1R/ARRB1 Mediated Regulation of ERK and cAMP Pathways in Response to Aβ Unfolds Novel Therapeutic Avenue in Alzheimer’s Disease
    Priyanka Sengupta, Debashis Mukhopadhyay · 2025 · Molecular Neurobiology
  76. Molekulare Medizin der Alzheimer-Krankheit
    Siegfried Hoyer, Lutz Frölich, Rupert Sandbrink · 1999 · Springer eBooks
  77. Ursachen und Behandlungskonzepte der Demenzen
    Hans Förstl, Hans J. Lauter, Horst Bickel · 2001 · VS Verlag für Sozialwissenschaften eBooks
  78. Tissue-Specific Targeting of the Insulin Receptor Gene
    Rohit Kulkarni, Terumasa Okada · 2002 · Endocrine
  79. In vitro and in vivo CRISPR-Cas9 screens reveal drivers of aging in neural stem cells of the brain
    Tyson Ruetz, Chloe M. Kashiwagi, Bhek Morton, Robin W. Yeo, D. Leeman, D. Morgens, C. K. Tsui, Amy Li, M. Bassik, A. Brunet · 2021 · bioRxiv
  80. Psychologically Traumatic Oxidative Stress; A Comprehensive Review of Redox Mechanisms and Related Inflammatory Implications
    Evangelos Karanikas · 2025 · Psychopharmacology Bulletin
  81. Species-specific sensitivity to intracerebroventricular streptozotocin in rats and mice highlights pathways and proteins relevant to Alzheimer’s disease
    Jan Homolak, Pavel Marković, Davor Virag, Ana Knezović, Jelena Osmanović Barilar, Andrija Loncar, Melita Šalković‐Petrišić, Ana Babić Perhoč · 2025 · Journal of Neural Transmission
  82. Sakharnyy diabet 2 tipa i kognitivnye narusheniya
    Lyudmila Alexandrovna Chugunova, Iya Vladimirovna Semenova, Yury Orlov, Marina Vladimirovna Shestakova · 2008 · Diabetes Mellitus
  83. H2O2 Signalling Pathway: A Possible Bridge between Insulin Receptor and Mitochondria
    Помыткин Игорь Анатольевич · 2012 · Current Neuropharmacology
  84. Putative Molecular Mechanisms Underpinning the Inverse Roles of Mitochondrial Respiration and Heme Function in Lung Cancer and Alzheimer’s Disease
    Atefeh Afsar, Zhang Li · 2024 · Biology
  85. Impaired insulin signaling and diet-induced type 3 diabetes pathophysiology increase amyloid β expression in the Drosophila model of Alzheimer's disease
    Khushboo Sharma, Pooja Rai, Madhu G. Tapadia · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  86. Evidence for the Control of Aggrecanases by Insulin and Glucose in Alzheimer's Disease
    Sümeyya Akyol, Veli Uğurcu, Özlem Çakmak, Aynur Altuntaş, Yunus Yükselten, Ömer Akyol, Asuman Sunguroğlu, Kadir Demircan · 2014 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
  87. The anterior chamber of the eye as a site for pancreatic islet transplantation
    Sijin Park, Dong Yun Lee · 2017 · Journal of Industrial and Engineering Chemistry
  88. Effect of a Novel Polyherbal Formulation on Diabetes Induced Memory Deficits in Rats
    2015 · Clinical and Experimental Pharmacology
  89. Prospects of intranasal insulin for correction of cognitive impairments, in particular those associated with diabetes mellitus
    Elena Viktorovna Surkova, Kira Viktorovna Derkach, Alexey I. Bespalov, Alexander Olegovich Shpakov · 2019 · Problems of Endocrinology
  90. The Correlation between Diabetes Mellitus and Neurodegenerative Diseases
    M Schubert · 2023 · Klinische Monatsblätter für Augenheilkunde
  91. DIABETES MELLITUS Y SU ASOCIACIÓN CON DETERIORO COGNITIVO Y DEMENCIA
    Gonzalo Muñoz A., Christina Degen, Johannes Schröder, Pablo Toro E. · 2016 · Revista Médica Clínica Las Condes
  92. Insulin and the Future Treatment of Alzheimer's Disease
    Roberta Semprini, Giacomo Koch, Lorena Belli, Francesco Di Lorenzo, Mauro Ragonese, Guglielmo Manenti, Gian Pio Sorice, Alessandro Martorana · 2016 · CNS & Neurological Disorders - Drug Targets
  93. Insulin signaling in the aging nervous system
    Eduardo Melani Rocha, Maria Luiza Fernandes, Licio Augusto Velloso · 2004 · Advances in cell aging and gerontology
  94. Insulin Resistance, Cognitive Impairment and Neurodegeneration: Roles of Nitrosamine Exposure, Diet and Lifestyles
    Suzanne de la Monte, Ming Tong, R. Jack · 2011 · InTech eBooks
  95. INSULINA Y ENFERMEDAD DE ALZHEIMER: UNA DIABETES TIPO 3?
    Andrés Jagua Gualdrón, Vladimir Ávila Ávila · 2007 · DOAJ (DOAJ: Directory of Open Access Journals)
  96. Fieldable flow injection analysis system with 1,1′-oxalyldiimidazolechemiluminescence detection capable of quantifying acetylcholine
    Hui Rak J. Kang, Kam Chan Kang, John G. Newby, Ji Hoon Lee · 2010 · Analytical Methods
  97. The Use of Anti-Diabetic Drugs in Alzheimer’s Disease, New Therapeutic Options and Future Perspective
    Osama Mohamed Ibrahim, Mariame A. Hassan · 2018 · Pharmacology &amp Pharmacy
  98. Diabetic Encephalopathy
    Geert Jan Biessels · 2008 · Humana Press eBooks
  99. Loss of Insulin Signaling in Microglia Impairs Cellular Uptake of Aβ and Neuroinflammatory Response Exacerbating Alzheimer-Like Neuropathology
    Wenqiang Chen, Xiangyu Liu, Vítor Rosetto Muñoz, C. Ronald Kahn · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Brain insulin resistance: a key pathological hub linking metabolic and neuropsychiatric comorbidities
    Shanwen Tang, Yifan Liao, Maoyi Yang, Rensong Yue · 2026 · Frontiers in Aging Neuroscience